Novozymes A/S (NVZMF) Stock Price, News & Analysis

Company Overview

Novozymes A/S (OTCMKTS: NVZMF) is a global leader in biological solutions, specializing in the development and production of industrial enzymes and microorganisms. The company’s products are designed to improve the efficiency and sustainability of a wide range of industries, including agriculture, bioenergy, food and beverage, household care, and textiles. By leveraging biotechnology, Novozymes helps customers reduce resource consumption, lower environmental impact, and optimize process performance.

Novozymes offers an extensive portfolio of enzyme products and microbial solutions that address specific industrial challenges such as starch conversion, biofuel production, and ingredient functionality in food processing. In addition to core enzyme products, the company provides digital tools and application support to integrate its solutions seamlessly into customer operations. This combination of technical expertise and tailored service models has positioned Novozymes as a trusted partner across multiple geographies.

Founded as part of Novo Nordisk’s enzyme division and established as an independent company in 2000, Novozymes is headquartered in Bagsværd, Denmark. It operates production and research facilities in Europe, the Americas and the Asia-Pacific region, serving customers in more than 100 countries. The company invests heavily in a global R&D network focused on protein engineering, fermentation technology and bioinnovation platforms.

Under the leadership of President and CEO Ester Baiget, Novozymes continues to advance its sustainability agenda by developing solutions that support circular economy principles and climate goals. The company collaborates with industry partners, academic institutions and non-governmental organizations to accelerate progress toward reduced waste, lower carbon emissions and improved resource stewardship worldwide.

Key Stats

• Today's Range: $61.81 to $61.81
• 50-Day Range: $61.49 to $71.72
• 52-Week Range: $53.55 to $75.97
• Volume: N/A
• Average Volume: 1,252 shs
• Market Capitalization: N/A
• P/E Ratio: 7.71
• Dividend Yield: 2.91%
• Price Target: N/A
• Consensus Rating: N/A

Novozymes A/S Stock Analysis - MarketRank™

Novozymes A/S scored higher than 7% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Novozymes A/S.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Novozymes A/S is 7.71, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 280.89.

Price to Earnings Ratio vs. Sector

The P/E ratio of Novozymes A/S is 7.71, which means that it is trading at a less expensive P/E ratio than the Basic Materials sector average P/E ratio of about 158.96.

Short Interest

• Score: 0.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Novozymes A/S has a short interest ratio ("days to cover") of 10867.5, which indicates bearish sentiment.

Change versus previous month

Short interest in Novozymes A/S has recently increased by 9.40%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.8 / 5
• Dividend Strength: Weak

Dividend Yield

Novozymes A/S has a dividend yield of 0.72%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Novozymes A/S does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Novozymes A/S is 22.44%. This payout ratio is at a healthy, sustainable level, below 75%.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Novozymes A/S has a short interest ratio ("days to cover") of 10867.5, which indicates bearish sentiment.

Change versus previous month

Short interest in Novozymes A/S has recently increased by 9.40%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 2.7 / 5
• News Sentiment: N/A

News Sentiment

Novozymes A/S has a news sentiment score of 0.84. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.61 average news sentiment score of Basic Materials companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Novozymes A/S this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Novozymes A/S insiders have not sold or bought any company stock.

Percentage Held by Institutions

Only 20.41% of the stock of Novozymes A/S is held by institutions.

NVZMF Stock Analysis - Frequently Asked Questions

How have NVZMF shares performed this year?

Novozymes A/S's stock was trading at $54.86 on January 1st, 2025. Since then, NVZMF stock has increased by 12.7% and is now trading at $61.81.

How were Novozymes A/S's earnings last quarter?

Novozymes A/S (OTCMKTS:NVZMF) issued its quarterly earnings data on Wednesday, April, 20th. The biotechnology company reported $0.37 EPS for the quarter, missing the consensus estimate of $2.43 by $2.06.

How do I buy shares of Novozymes A/S?

Shares of NVZMF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 4/20/2016
• Today: 9/14/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Basic Materials
• Industry: Specialty Chemicals
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:NVZMF
• CIK: 1131345
• Web: www.novozymes.com
• Phone: (454) 446-0000
• Fax: N/A
• Employees: 10,452
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 7.71
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A